R21 Roche: 3-Way Tau Tracers in AD

NCT05464368 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: [18F]RO-948
DRUG: 18F-MK6240
DRUG: 18F-GTP1

Sponsor

Washington University School of Medicine

Collaborators

[object Object]